A major trial in frontotemporal dementia patients has found that oxytocin can help improve symptoms of apathy. A new study led by Western researchers suggests that frequent treatment with intranasal o ...
A new study led by Western researchers found frequent treatment with intranasal oxytocin – a hormone in the brain associated ...
New drug approvals and a federal dementia care pilot program among the year's significant developments, according to the ...
ATx has created groundbreaking drugs for dementia and Alzheimer’s. The Icelandic startup just raised €26mn to advance the ...
The FDA approves a new maintenance dosing regimen for lecanemab (Leqembi; Eisai) in patients with early-stage Alzheimer ...
Gaps remain in biomedical research in frontotemporal dementia; however, there are several means by which these gaps can be bridged.
Researchers at the University of Kentucky's Sanders-Brown Center on Aging are at the forefront of advancing dementia research ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback